keyword
Keywords Pain management palliative neu...

Pain management palliative neuropathic

https://read.qxmd.com/read/38647694/a-qualitative-evaluation-of-the-oncologists-neurologists-and-pain-specialists-views-on-the-management-and-care-of-chemotherapy-induced-peripheral-neuropathy-in-the-netherlands
#1
JOURNAL ARTICLE
F G A M van Haren, M A H Steegers, K C P Vissers, S A S van den Heuvel
PURPOSE: In treating cancer, different chemotherapy regimens cause chemotherapy-induced peripheral neuropathy (CIPN). Despite recent international guidelines, a gold standard for diagnosis, treatment, and care is lacking. To identify the current clinical practice and the physicians' point of view and ideas for improvement, we evaluated CIPN care by interviewing different specialists involved. METHODS: We performed semi-structured, audio-recorded, transcribed, and coded interviews with a purposive sample of oncologists, pain specialists, and neurologists involved in CIPN patients' care...
April 22, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38451483/neuropathic-pain-after-surgery-a-clinical-validation-study-and-assessment-of-accuracy-measures-of-the-5-item-neupps-scale
#2
JOURNAL ARTICLE
Kenneth Geving Andersen, Karl Bang Christensen, Henrik Kehlet, Mathias Kvist Mejdahl
OBJECTIVE: The aim of this study was to validate the Neuropathic Pain for Post-Surgical Patients (NeuPPS) scale against clinically verified neuropathic pain (NP) by quantitative sensory testing (QST) as well as evaluation of other psychometric properties. The NeuPPS is a validated 5-item scale designed to evaluate NP in surgical populations. METHODS: Data from 537 women aged >18 years scheduled for primary breast cancer surgery enrolled in a previous study for assessing risk factors for persistent pain after breast cancer treatment were used...
January 1, 2024: Scandinavian Journal of Pain
https://read.qxmd.com/read/38444061/subcutaneous-sodium-valproate-in-palliative-care-a-systematic-review
#3
JOURNAL ARTICLE
Sheryn Tan, Jeng Swen Ng, Charis Tang, Brandon Stretton, Joshua Kovoor, Aashray Gupta, Thomson Delloso, Tony Zhang, Rudy Goh, Shaddy El-Masri, Michelle Kiley, Ian Maddocks, Adil Harroud, Sybil Stacpoole, Gregory Crawford, Stephen Bacchi
BACKGROUND: Seizures are an important palliative symptom, the management of which can be complicated by patients' capacity to swallow oral medications. In this setting, and the wish to avoid intravenous access, subcutaneous infusions may be employed. Options for antiseizure medications that can be provided subcutaneously may be limited. Subcutaneous sodium valproate may be an additional management strategy. AIM: To evaluate the published experience of subcutaneous valproate use in palliative care, namely with respect to effectiveness and tolerability...
March 5, 2024: Palliative Medicine
https://read.qxmd.com/read/38440795/peripheral-nerve-stimulation-for-psoas-muscle-pain
#4
JOURNAL ARTICLE
Syn Hae Yoon, Precious Tabansi, Saba Javed
The psoas muscle is the largest muscle in the lower lumbar spine and is innervated by the ipsilateral lumbar spinal nerve roots (L2-L4). Here, we present a 44-year-old female with left hip pain in the posterolateral aspect of the left hip radiating to the ipsilateral hamstring, and psoas atrophy (based on imaging). She is now reported to have over 50% improvement in pain scores after underdoing temporary peripheral nerve stimulation (PNS) of the psoas muscle as well as significant improvement in muscle atrophy based on an electromyography (EMG) study...
March 5, 2024: Pain Management
https://read.qxmd.com/read/38417464/palliative-medicine-fellows-discussions-perceptions-and-training-regarding-medical-cannabis
#5
JOURNAL ARTICLE
Dylan R Sherry, Rushad Patell, Harry J Han, Laura E Dodge, Ilana M Braun, Mary K Buss
INTRODUCTION: Medical cannabis is increasingly considered for palliation of pain, nausea/vomiting, anorexia, and other symptoms. We aimed to determine whether training in hospice and palliative medicine (HPM) adequately prepares fellows to counsel patients about medical cannabis. METHODS: A previously validated questionnaire was adapted for HPM fellows. Domains included fellows' practices recommending cannabis and their knowledge of its effectiveness and risks compared with standard treatments...
February 26, 2024: Journal of Pain and Symptom Management
https://read.qxmd.com/read/38389624/caudal-neuraxial-blocks-for-pain-relief-from-pelvic-neuropathy-caused-by-extensive-diffuse-large-b-cell-lymphoma
#6
Amanda Myles, Ammar Toubasi, Elizabeth Soladoye, Narayana Gowda, Joan Morny
Central neuraxial blocks can be a vital therapeutic tool for neuropathic pain, but they are infrequently implemented for pain management in cancer patients. Upon a literature review, further data on the role or efficacy of central nerve blocks for neuropathic cancer pain would be beneficial. Additionally, evidence-based guidelines and practices are lacking regarding additional interventions for neuropathic pain relief, a common manifestation of cancer burden. Here, we report the case of a 29-year-old male patient who presented in the ED with intractable neuropathic pain from extensive diffuse large B-cell lymphoma...
January 2024: Curēus
https://read.qxmd.com/read/38375093/application-and-accuracy-of-the-eapc-iasp-diagnostic-algorithm-for-neuropathic-cancer-pain-and-quantitative-sensory-testing-profile-in-patients-with-pain-due-to-cancer
#7
JOURNAL ARTICLE
Morena Shkodra, Matthew Mulvey, Marie Fallon, Cinzia Brunelli, Ernesto Zecca, Paola Bracchi, Mariangela Caputo, Giacomo Massa, Silvia Lo Dico, Roman Rolke, Stein Kaasa, Augusto Caraceni
INTRODUCTION: Better diagnosis and treatment of neuropathic cancer pain (NcP) remains an unmet clinical need. The EAPC/IASP algorithm was specifically designed for NcP diagnosis; yet, to date, there is no information on its application and accuracy. OBJECTIVES: Our aim was to determine the accuracy of the EAPC/IASP algorithm compared with the Neuropathic Special Interest Group grading system (gold standard) and to describe patients' sensory profile with quantitative sensory testing (QST)...
April 2024: Pain Reports
https://read.qxmd.com/read/38374447/the-role-of-spirituality-in-pain-experiences-among-adults-with-cancer-an-explanatory-sequential-mixed-methods-study
#8
JOURNAL ARTICLE
Megan Miller, Stephanie Speicher, Katie Hardie, Roger Brown, William E Rosa
PURPOSE: Foundational research demonstrates that spirituality may affect the way people with cancer experience pain. One potential route is through alterations in thoughts and beliefs, such as pain-related catastrophizing. The purpose of this study is to understand whether spirituality impacts pain experiences through pain-related catastrophizing. METHODS: This explanatory sequential mixed methods study was informed by an adapted Theory of Unpleasant Symptoms. Data were collected via online surveys (N = 79) and follow-up qualitative interviews (N = 25)...
February 20, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38300182/a-pathophysiological-approach-for-selecting-medications-to-treat-nociceptive-and-neuropathic-pain-in-servicemembers
#9
JOURNAL ARTICLE
Khan Thi Nguyen, Daniel W Beauchamp, Reginald B O'Hara
INTRODUCTION: The prevalence of chronic pain of service members (SMs) in the U.S. is estimated to be higher (roughly 31-44%) compared to that of civilian population (26%). This higher prevalence is likely due to the high physical demands related combat and training injuries that are not immediately resolved and worsen over time. Mental Health America reports that chronic pain can lead to other mental health conditions such as severe anxiety, depression, bipolar disorder, and post-traumatic stress disorder...
January 31, 2024: Military Medicine
https://read.qxmd.com/read/38193288/diagnostic-and-therapeutic-value-of-intracellular-biomarker-testing-in-chronic-pain
#10
JOURNAL ARTICLE
Alice L Ye, Emily W Sudek, Daniela Magdaleno, Carlos J Roldan
Aim: Micronutrient and metabolic compound supplementation as a method of treating chronic pain is not well understood. Case: A 58 year-old woman presented with refractory painful neuropathy. She did not respond to conservative treatment and was seeking spinal cord stimulator implantation. She underwent a biomarker panel that revealed low intracellular levels of multiple compounds. As she supplemented her deficiencies, her symptoms fully resolved, and the implant was no longer indicated. Discussion: Micronutrient and metabolic compound testing could potentially expand non-invasive treatment options for patients with refractory chronic pain...
January 9, 2024: Pain Management
https://read.qxmd.com/read/38189105/case-report-use-of-high-intensity-laser-therapy-for-treatment-of-trigeminal-neuralgia
#11
JOURNAL ARTICLE
Diego M Martinez, Billy K Huh, Saba Javed
Trigeminal neuralgia represents a form of chronic facial pain that is characterized by its incapacitating nature. The current therapeutic approaches encompass pharmacological agents with carbamazepine or non-pharmacologic options including utilization of percutaneous rhizotomy, Gamma knife radiosurgery or microvascular decompression may be indicated in certain cases. While the interventions may be effective, medications have negative side effects and procedures are invasive which can pose challenges for patients with various comorbidities...
January 8, 2024: Pain Management
https://read.qxmd.com/read/38070164/bridging-the-translational-gap-adenosine-as-a-modulator-of-neuropathic-pain-in-preclinical-models-and-humans
#12
JOURNAL ARTICLE
Lars Arendt-Nielsen, Henrik Klitgaard, Stine N Hansen
OBJECTIVES: This review aims to analyse the published data on preclinical and human experimental and clinical adenosine modulation for pain management. We summarise the translatability of the adenosine pathway for further drug development and aim to reveal subgroups of pain patients that could benefit from targeting the pathway. CONTENT: Chronic pain patients suffer from inadequate treatment options and drug development is generally impaired by the low translatability of preclinical pain models...
December 11, 2023: Scandinavian Journal of Pain
https://read.qxmd.com/read/38060737/trigeminal-neuralgia-in-advanced-head-and-neck-cancer-a-complex-palliative-care-case
#13
Carolina Vidal, Rosário Vidal
Trigeminal neuralgia (TN) is a chronic neuropathic pain disorder characterized by paroxysms of electric shock-like or stabbing pain in the face. This condition is associated with poor quality of life. First-line treatment includes carbamazepine or oxcarbazepine, but some cases show refractory symptoms to this approach. We describe a challenging case of secondary TN due to an advanced head and neck cancer managed by a palliative care team.
November 2023: Curēus
https://read.qxmd.com/read/38054404/enhancing-post-operative-analgesia-following-spinal-cord-stimulation-implant-a-comprehensive-evaluation-of-the-effectiveness-of-erector-spinae-plane-block-utilizing-liposomal-bupivacaine
#14
JOURNAL ARTICLE
Afrin Sagir, Melissa Murphy, Richard Teames, Doug Calenda
Erector spinae plane block (ESPB) is an inter-fascial plane block that provides multi-dermatomal analgesia for treatment of acute pain and chronic neuropathic pain in the trunk. This retrospective case series describes a novel method of treating acute postoperative pain after spinal cord stimulation implant with erector spinae plane block using liposomal bupivacaine. Bilateral erector spinae plane block was administered at L1-L2 intervertebral level in 18 cases prior to performing spinal cord stimulation implant at one interspace above...
December 2023: Pain Management
https://read.qxmd.com/read/38037828/exploring-new-horizons-in-pain-relief-introducing-volume-14-of-pain-management
#15
JOURNAL ARTICLE
Jasmine Hagan
To our readers, welcome to the first issue of Volume 14 of Pain Management. 2023 marked a significant year for the journal, as we received an impact factor of 1.7 and increased the number of issues from 8 to 12. This foreword presents some of our content highlights from 2023, covering our top articles from the year and providing you with an insight into what to expect in the forthcoming year.
December 1, 2023: Pain Management
https://read.qxmd.com/read/38036114/gabapentin-for-pain-in-pediatric-palliative-care
#16
JOURNAL ARTICLE
Ross Drake, Grace Prael, Yinyin Phyo, Sungwon Chang, Jane Hunt, Anthony Herbert, Christine Mott, Jenny Hynson, Marianne Phillips, Mary Cossich, Martha Mherekumombe, Min Sun Kim, Poh Heng Chong, Maja Abitz, Mercedes Bernada, Madeline Avery, Matt Doogue, Debra Rowett, David Currow
OBJECTIVE: Gabapentin is commonly used to treat pain in children receiving pediatric palliative care. This study describes the real-world use of gabapentin and the associated benefits and adverse effects/events (AEs). METHODS: A prospective, multicenter cohort of standardized data collection after a clinical decision was made to use gabapentin for managing neuropathic or nociplastic pain in children attended on by a pediatric palliative care service. It was conducted across 11 sites in seven countries including hospital, inpatient, and outpatient services...
November 29, 2023: Journal of Pain and Symptom Management
https://read.qxmd.com/read/38010998/the-use-of-ketamine-for-malignant-and-nonmalignant-chronic-pain-in-children-a-review-of-current-evidence
#17
REVIEW
Khaled AlGhamdi, Kim Sadler
Chronic pain in children continues to pose significant challenges. The pharmacological approach most often revolves around trials and errors, expert opinions, and extrapolation of adult study findings. Ketamine is one of the agents used for chronic pain, especially with a neuropathic component. This article aims to provide an overview of its properties and highlight the current evidence for its use in malignant and nonmalignant chronic pain management. A search on the use of ketamine for chronic pain in children up to 18 years of age covering the period from January 1, 2000, to December 14, 2022, was performed through PubMed, Cochrane Library, EBSCO, EBM Review, Wiley, BMJ, Web of Science, Google Scholar, and the Saudi Digital Library...
March 2024: Journal of Pain & Palliative Care Pharmacotherapy
https://read.qxmd.com/read/37929332/spinal-cord-stimulation-for-visceral-pain-associated-with-medullary-sponge-kidney
#18
JOURNAL ARTICLE
Naveed S Noordin, Cody J Cox, Michael M Wilkinson, Eellan Sivanesan, Yian Chen
Chronic pain is a common reason for which people in the USA seek medical care. It is linked to opioid consumption, anxiety and a reduction in quality of life. Over the past 50 years, spinal cord stimulation (SCS) has evolved as a safe and efficacious treatment for chronic pain etiologies. The authors present the first known case of SCS for pain due to medullary sponge kidney disease. This report adds to the growing body of literature supporting the use of SCS for treating visceral organ pain, while also highlighting the utility of ventral lead placement for treating visceral pain...
November 6, 2023: Pain Management
https://read.qxmd.com/read/37863373/routine-monitoring-of-qtc-interval-as-a-barrier-for-efficient-use-of-methadone-in-palliative-care
#19
JOURNAL ARTICLE
Varsha Pawate, Jaya Sheela Amaram Davila, Akhila Reddy, Eduardo Bruera
BACKGROUND: Methadone is a commonly prescribed opioid amongst cancer patients. It has unique pharmacological properties which can benefit in treating complex pain syndromes and neuropathic pain. However, strict guidelines have been created in a generalized manner for chronic pain and long-term survival patients. These guidelines, such as QT interval monitoring can lead to limitations for methadone use in patients with comfort associated goals. We present two cases of patients with metastatic cancer who were treated for pain with methadone and had to undergo opioid rotation due to abnormal QT interval...
October 18, 2023: Journal of Pain and Symptom Management
https://read.qxmd.com/read/37750226/painful-diabetic-peripheral-neuropathy-of-the-feet-integrating-prescription-strength-capsaicin-into-office-procedures
#20
REVIEW
Orlando Landrum, Lizandra Marcondes, Toni Egharevba, Karina Gritsenko
Prescription-strength (8%) capsaicin topical system is a US FDA-approved treatment for painful diabetic peripheral neuropathy of the feet. A 30 min application of the capsaicin 8% topical system can provide sustained (up to 3 months) local pain relief by desensitizing and reducing TRPV1-expressing cutaneous fibers. Capsaicin is not absorbed systemically; despite associated application-site discomfort, capsaicin 8% topical system is well tolerated, with no known drug interactions or contraindications, and could offer clinical advantages over oral options...
September 26, 2023: Pain Management
keyword
keyword
50510
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.